vs
Side-by-side financial comparison of Organon & Co. (OGN) and HANOVER INSURANCE GROUP, INC. (THG). Click either name above to swap in a different company.
HANOVER INSURANCE GROUP, INC. is the larger business by last-quarter revenue ($1.7B vs $1.5B, roughly 1.1× Organon & Co.). HANOVER INSURANCE GROUP, INC. runs the higher net margin — 11.0% vs -13.6%, a 24.6% gap on every dollar of revenue. On growth, HANOVER INSURANCE GROUP, INC. posted the faster year-over-year revenue change (6.1% vs -5.3%). Over the past eight quarters, HANOVER INSURANCE GROUP, INC.'s revenue compounded faster (5.2% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
The Hanover Insurance Group, Inc. is an insurance company based in Worcester, Massachusetts. It was the original name of a property-liability insurance firm established in 1852, and it remained a publicly traded company under that name until the early 1990s, when it changed its name to Allmerica Property & Casualty Companies.
OGN vs THG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.7B |
| Net Profit | $-205.0M | $186.8M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | 11.1% |
| Net Margin | -13.6% | 11.0% |
| Revenue YoY | -5.3% | 6.1% |
| Net Profit YoY | -288.1% | 45.7% |
| EPS (diluted) | $-0.78 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.5B | $1.7B | ||
| Q3 25 | $1.6B | $1.7B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.5B | $1.6B | ||
| Q4 24 | $1.6B | $1.6B | ||
| Q3 24 | $1.6B | $1.6B | ||
| Q2 24 | $1.6B | $1.5B |
| Q1 26 | — | $186.8M | ||
| Q4 25 | $-205.0M | $198.5M | ||
| Q3 25 | $160.0M | $178.7M | ||
| Q2 25 | $145.0M | $157.1M | ||
| Q1 25 | $87.0M | $128.2M | ||
| Q4 24 | $109.0M | $167.9M | ||
| Q3 24 | $359.0M | $102.1M | ||
| Q2 24 | $195.0M | $40.5M |
| Q1 26 | — | — | ||
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — |
| Q1 26 | — | 11.1% | ||
| Q4 25 | -9.8% | 17.3% | ||
| Q3 25 | 15.2% | 14.9% | ||
| Q2 25 | 14.4% | 12.7% | ||
| Q1 25 | 6.7% | 11.6% | ||
| Q4 24 | 8.1% | 16.1% | ||
| Q3 24 | 13.1% | 9.6% | ||
| Q2 24 | 14.6% | 6.2% |
| Q1 26 | — | 11.0% | ||
| Q4 25 | -13.6% | 11.9% | ||
| Q3 25 | 10.0% | 10.7% | ||
| Q2 25 | 9.1% | 9.5% | ||
| Q1 25 | 5.8% | 8.0% | ||
| Q4 24 | 6.8% | 10.6% | ||
| Q3 24 | 22.7% | 6.5% | ||
| Q2 24 | 12.1% | 2.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.78 | $5.46 | ||
| Q3 25 | $0.61 | $4.90 | ||
| Q2 25 | $0.56 | $4.30 | ||
| Q1 25 | $0.33 | $3.50 | ||
| Q4 24 | $0.42 | $4.60 | ||
| Q3 24 | $1.38 | $2.80 | ||
| Q2 24 | $0.75 | $1.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $243.5M |
| Total DebtLower is stronger | $8.6B | $843.8M |
| Stockholders' EquityBook value | $752.0M | $3.0B |
| Total Assets | $12.9B | $16.5B |
| Debt / EquityLower = less leverage | 11.49× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $243.5M | ||
| Q4 25 | $574.0M | $1.1B | ||
| Q3 25 | $672.0M | $915.7M | ||
| Q2 25 | $599.0M | $244.1M | ||
| Q1 25 | $547.0M | $315.1M | ||
| Q4 24 | $675.0M | $435.5M | ||
| Q3 24 | $763.0M | $427.1M | ||
| Q2 24 | $704.0M | $337.6M |
| Q1 26 | — | $843.8M | ||
| Q4 25 | $8.6B | $843.3M | ||
| Q3 25 | $8.8B | $843.0M | ||
| Q2 25 | $8.9B | $347.8M | ||
| Q1 25 | $9.0B | $722.5M | ||
| Q4 24 | $8.9B | $722.3M | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $752.0M | $3.6B | ||
| Q3 25 | $906.0M | $3.4B | ||
| Q2 25 | $733.0M | $3.2B | ||
| Q1 25 | $542.0M | $3.0B | ||
| Q4 24 | $472.0M | $2.8B | ||
| Q3 24 | $493.0M | $2.9B | ||
| Q2 24 | $144.0M | $2.6B |
| Q1 26 | — | $16.5B | ||
| Q4 25 | $12.9B | $16.9B | ||
| Q3 25 | $13.6B | $16.8B | ||
| Q2 25 | $13.5B | $15.7B | ||
| Q1 25 | $13.2B | $15.5B | ||
| Q4 24 | $13.1B | $15.3B | ||
| Q3 24 | $12.8B | $15.4B | ||
| Q2 24 | $12.2B | $14.9B |
| Q1 26 | — | 0.28× | ||
| Q4 25 | 11.49× | 0.24× | ||
| Q3 25 | 9.74× | 0.25× | ||
| Q2 25 | 12.14× | 0.11× | ||
| Q1 25 | 16.52× | 0.24× | ||
| Q4 24 | 18.81× | 0.25× | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | — |
| Free Cash FlowOCF − Capex | $96.0M | — |
| FCF MarginFCF / Revenue | 6.4% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $141.0M | $378.2M | ||
| Q3 25 | $264.0M | $554.4M | ||
| Q2 25 | $220.0M | $206.6M | ||
| Q1 25 | $75.0M | $38.9M | ||
| Q4 24 | $390.0M | $213.5M | ||
| Q3 24 | $141.0M | $394.7M | ||
| Q2 24 | $332.0M | $139.5M |
| Q1 26 | — | — | ||
| Q4 25 | $96.0M | $377.0M | ||
| Q3 25 | $218.0M | $551.4M | ||
| Q2 25 | $181.0M | $204.9M | ||
| Q1 25 | $43.0M | $37.1M | ||
| Q4 24 | $335.0M | $210.5M | ||
| Q3 24 | $99.0M | $392.3M | ||
| Q2 24 | $300.0M | $137.3M |
| Q1 26 | — | — | ||
| Q4 25 | 6.4% | 22.6% | ||
| Q3 25 | 13.6% | 33.1% | ||
| Q2 25 | 11.4% | 12.4% | ||
| Q1 25 | 2.8% | 2.3% | ||
| Q4 24 | 21.0% | 13.3% | ||
| Q3 24 | 6.3% | 25.1% | ||
| Q2 24 | 18.7% | 8.9% |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | 0.1% | ||
| Q3 25 | 2.9% | 0.2% | ||
| Q2 25 | 2.4% | 0.1% | ||
| Q1 25 | 2.1% | 0.1% | ||
| Q4 24 | 3.5% | 0.2% | ||
| Q3 24 | 2.7% | 0.2% | ||
| Q2 24 | 2.0% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.91× | ||
| Q3 25 | 1.65× | 3.10× | ||
| Q2 25 | 1.52× | 1.32× | ||
| Q1 25 | 0.86× | 0.30× | ||
| Q4 24 | 3.58× | 1.27× | ||
| Q3 24 | 0.39× | 3.87× | ||
| Q2 24 | 1.70× | 3.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
THG
| Premiums earned | $1.6B | 92% |
| Other | $124.6M | 7% |
| Fees and other income | $6.2M | 0% |
